Literature DB >> 18073128

Motor coordination deficits in mice lacking RGS9.

Jacqueline Blundell1, Chau V Hoang, Bryan Potts, Stephen J Gold, Craig M Powell.   

Abstract

RGS9-2 is a striatum-enriched protein that negatively modulates dopamine and opioid receptor signaling. We examined the role of RGS9-2 in modulating complex behavior. Genetic deletion of RGS9-2 does not lead to global impairments, but results in selective abnormalities in certain behavioral domains. RGS9 knockout (KO) mice have decreased motor coordination on the accelerating rotarod and deficits in working memory as measured in the delayed-match-to-place version of the water maze. In contrast, RGS9 KO mice exhibit normal locomotor activity, anxiety-like behavior, cue and contextual fear conditioning, startle threshold, and pre-pulse inhibition. These studies are the first to describe a role for RGS9-2 in motor coordination and working memory and implicate RGS9-2 as a potential therapeutic target for motor and cognitive dysfunction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18073128      PMCID: PMC2241663          DOI: 10.1016/j.brainres.2007.11.017

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  57 in total

1.  Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA-antagonist D-AP5.

Authors:  R J Steele; R G Morris
Journal:  Hippocampus       Date:  1999       Impact factor: 3.899

2.  Comparison of the effects of frontal and caudate lesions on delayed response and alternation in monkeys.

Authors:  K BATTIG; H E ROSVOLD; M MISHKIN
Journal:  J Comp Physiol Psychol       Date:  1960-08

3.  D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways.

Authors:  Abraham Kovoor; Petra Seyffarth; Jana Ebert; Sami Barghshoon; Ching-Kang Chen; Sigrid Schwarz; Jeffrey D Axelrod; Benjamin N R Cheyette; Melvin I Simon; Henry A Lester; Johannes Schwarz
Journal:  J Neurosci       Date:  2005-02-23       Impact factor: 6.167

4.  RGS9: a regulator of G-protein signalling with specific expression in rat and mouse striatum.

Authors:  E A Thomas; P E Danielson; J G Sutcliffe
Journal:  J Neurosci Res       Date:  1998-04-01       Impact factor: 4.164

5.  Effects of medial and lateral caudate-putamen lesions on place- and cue-guided behaviors in the water maze: relation to thigmotaxis.

Authors:  B D Devan; R J McDonald; N M White
Journal:  Behav Brain Res       Date:  1999-04       Impact factor: 3.332

Review 6.  Regulators of G protein signaling & drugs of abuse.

Authors:  John R Traynor; Richard R Neubig
Journal:  Mol Interv       Date:  2005-02

7.  Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations.

Authors:  M A Kelly; M Rubinstein; T J Phillips; C N Lessov; S Burkhart-Kasch; G Zhang; J R Bunzow; Y Fang; G A Gerhardt; D K Grandy; M J Low
Journal:  J Neurosci       Date:  1998-05-01       Impact factor: 6.167

8.  Cloning and characterization of RGS9-2: a striatal-enriched alternatively spliced product of the RGS9 gene.

Authors:  Z Rahman; S J Gold; M N Potenza; C W Cowan; Y G Ni; W He; T G Wensel; E J Nestler
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

Review 9.  Imaging dopamine transmission in schizophrenia. A review and meta-analysis.

Authors:  M Laruelle
Journal:  Q J Nucl Med       Date:  1998-09

10.  Molecular characterization of human and rat RGS 9L, a novel splice variant enriched in dopamine target regions, and chromosomal localization of the RGS 9 gene.

Authors:  J G Granneman; Y Zhai; Z Zhu; M J Bannon; S A Burchett; C J Schmidt; R Andrade; J Cooper
Journal:  Mol Pharmacol       Date:  1998-10       Impact factor: 4.436

View more
  30 in total

1.  Subcellular localization of regulator of G protein signaling RGS7 complex in neurons and transfected cells.

Authors:  Evangelos Liapis; Simone Sandiford; Qiang Wang; Gabriel Gaidosh; Dario Motti; Konstantin Levay; Vladlen Z Slepak
Journal:  J Neurochem       Date:  2012-06-22       Impact factor: 5.372

2.  RGS9-2: probing an intracellular modulator of behavior as a drug target.

Authors:  John R Traynor; Dimitra Terzi; Barbara J Caldarone; Venetia Zachariou
Journal:  Trends Pharmacol Sci       Date:  2009-02-09       Impact factor: 14.819

3.  Knockout of G protein β5 impairs brain development and causes multiple neurologic abnormalities in mice.

Authors:  Jian-Hua Zhang; Mritunjay Pandey; Erica M Seigneur; Leelamma M Panicker; Lily Koo; Owen M Schwartz; Weiping Chen; Ching-Kang Chen; William F Simonds
Journal:  J Neurochem       Date:  2011-09-23       Impact factor: 5.372

4.  Selective Role of RGS9-2 in Regulating Retrograde Synaptic Signaling of Indirect Pathway Medium Spiny Neurons in Dorsal Striatum.

Authors:  Chenghui Song; Garret R Anderson; Laurie P Sutton; Maria Dao; Kirill A Martemyanov
Journal:  J Neurosci       Date:  2018-07-13       Impact factor: 6.167

5.  Photophobia and abnormally sustained pupil responses in a mouse model of bradyopsia.

Authors:  Adisa Kuburas; Stewart Thompson; Nikolai O Artemyev; Randy H Kardon; Andrew F Russo
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-25       Impact factor: 4.799

Review 6.  The evolution of regulators of G protein signalling proteins as drug targets - 20 years in the making: IUPHAR Review 21.

Authors:  B Sjögren
Journal:  Br J Pharmacol       Date:  2017-02-08       Impact factor: 8.739

7.  The relationship between slow photoresponse recovery rate and temporal resolution of vision.

Authors:  Yumiko Umino; Rolf Herrmann; Ching-Kang Chen; Robert B Barlow; Vadim Y Arshavsky; Eduardo Solessio
Journal:  J Neurosci       Date:  2012-10-10       Impact factor: 6.167

8.  D(2)-Dopamine receptors target regulator of G protein signaling 9-2 to detergent-resistant membrane fractions.

Authors:  Jeremy Celver; Meenakshi Sharma; Abraham Kovoor
Journal:  J Neurochem       Date:  2011-11-24       Impact factor: 5.372

9.  Retina-specific GTPase accelerator RGS11/G beta 5S/R9AP is a constitutive heterotrimer selectively targeted to mGluR6 in ON-bipolar neurons.

Authors:  Yan Cao; Ikuo Masuho; Haruhisa Okawa; Keqiang Xie; Junko Asami; Paul J Kammermeier; Dennis M Maddox; Takahisa Furukawa; Takayoshi Inoue; Alapakkam P Sampath; Kirill A Martemyanov
Journal:  J Neurosci       Date:  2009-07-22       Impact factor: 6.167

Review 10.  R9AP and R7BP: traffic cops for the RGS7 family in phototransduction and neuronal GPCR signaling.

Authors:  Muralidharan Jayaraman; Hao Zhou; Lixia Jia; Matthew D Cain; Kendall J Blumer
Journal:  Trends Pharmacol Sci       Date:  2008-11-29       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.